Medicalgorithmics SA stock news
Medicalgorithmics SA announced that the General Meeting of Shareholders held on July 15, 2026, successfully approved the resolution to increase the share capital through the issuance of Series Q shares. These shares are designated for the major shareholder, Biofund Capital Management LLC, as part of a debt--to--equity conversion of the 2024 loan at a price of PLN 33.00 per share. This transaction effectively eliminates PLN 13.2 million in liabilities from the balance sheet, significantly strengthening the company's equity position and improving its financial stability for future strategic initiatives.